Publication:
Chemotherapy-Induced Cognitive Impairment

dc.contributor.authorDokuzlar O.
dc.contributor.authorSOYSAL P.
dc.contributor.authorIŞIK A. T.
dc.date.accessioned2025-06-09T21:50:29Z
dc.date.issued2020-01-01
dc.description.abstractToday, with the advances in cancer treatments, survival times have increased, which has made treatment side effects more important. Cancer-related cognitive insufficiency is one of the problems that may arise during or after treatment. Especially, memory, attention, executive functions and negative effects of psychomotor speed have been shown. It is important for both the patient and the caregivers to affect the quality of life and the increase in health expenditures. Many factors are responsible for the pathogenesis. Although there is currently no specific treatment, there are agents that show benefit. Routine screening seems to be important for early diagnosis and treatment of patients.
dc.identifier.citationDokuzlar O., SOYSAL P., IŞIK A. T., "Chemotherapy-Induced Cognitive Impairment", TIBBI ONKOLOJI - GERIATRIK ONKOLOJI, ss.29-33, 2020
dc.identifier.urihttps://hdl.handle.net/20.500.12645/40693
dc.identifier.wosWOS:000773800000007
dc.rightsinfo:eu-repo/semantics/openAccess
dc.subjectTıp
dc.subjectDahili Tıp Bilimleri
dc.subjectİç Hastalıkları
dc.subjectOnkoloji
dc.subjectGeriatri
dc.subjectSağlık Bilimleri
dc.subjectMedicine
dc.subjectInternal Medicine Sciences
dc.subjectInternal Diseases
dc.subjectOncology
dc.subjectGeriatrics
dc.subjectHealth Sciences
dc.subjectKlinik Tıp
dc.subjectKlinik Tıp (Med)
dc.subjectGeriatri ve Gerontoloji
dc.subjectClinical Medicine
dc.subjectClinical Medicine (Med)
dc.subjectGeriatrics & Gerontology
dc.subjectGeriatrics and Gerontology
dc.titleChemotherapy-Induced Cognitive Impairment
dc.typearticle
dspace.entity.typePublication
local.avesis.id240b49e0-3947-438f-acc3-002ef0a41de0

Files